Back to top

Wedbush Remains a Buy on First Tracks Biotherapeutics Inc (TRAX)

Wedbush analyst Martin Fan maintained a Buy rating on First Tracks Biotherapeutics Inc today and set a price target of $60.00. Fan covers the Healt...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: